Plaque

·MeSH: Plaque, Amyloid

67 drugs in development·31 companies·1 clinical trial

Drug Pipeline by Phase

Approved(12)

Drug	Company
abrilada	PFIZER INC (PFE)
Brenzys (SB4)	Organon & Co. (OGN)
Hadlima (SB5)	Organon & Co. (OGN)
imuldosa	Acorda Therapeutics, Inc. (ACOR)
neuraceq	Lantheus Holdings, Inc. (LNTH)
Renflexis (SB2)	Organon & Co. (OGN)
Taltz	ELI LILLY & Co (LLY)
Taltz®	ELI LILLY & Co (LLY)
Tremfya	Royalty Pharma plc (RPRX)
vizamyl	GE HealthCare Technologies Inc. (GEHC)
wezlana	AMGEN INC (AMGN)
yesintek	Bone Biologics Corp (BBLG)

Phase 3(26)

Drug	Company
adalimumab	GT Biopharma, Inc. (GTBP)
bimekizumab	Cue Biopharma, Inc. (CUE)
bimekizumab	POINT Biopharma Global Inc. (PNT)
blinded envudeucitinib	ALUMIS INC. (ALMS)
Blinded ESK-001	ALUMIS INC. (ALMS)
envudeucitinib	ALUMIS INC. (ALMS)
ESK-001	ALUMIS INC. (ALMS)
guselkumab	GH Research PLC (GHRS)
ICP-488 Tablets	Crinetics Pharmaceuticals, Inc. (CRNX)
jnj-77242113	GH Research PLC (GHRS)
JNJ-77242113	ENANTA PHARMACEUTICALS INC (ENTA)
open-label envudeucitinib	ALUMIS INC. (ALMS)
Open-Label ESK-001	ALUMIS INC. (ALMS)
piclidenoson	Can-Fite BioPharma Ltd. (CANF)
Risankizumab	AbbVie Inc. (ABBV)
secukinumab	GT Biopharma, Inc. (GTBP)
tak-279	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
tak-279	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
tapinarof cream 1%	Teva Pharmaceutical Industries Limited (TEVA)
tapinarof cream 1%	TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVJF)
ustekinumab	GT Biopharma, Inc. (GTBP)
ustekinumab	POINT Biopharma Global Inc. (PNT)
Ustekinumab	BRISTOL MYERS SQUIBB CO (BMY)
Vehicle cream	Organon & Co. (OGN)
vtama	TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVJF)
vtama	Teva Pharmaceutical Industries Limited (TEVA)

Phase 2(11)

Drug	Company
bimekizumab	GT Biopharma, Inc. (GTBP)
JNJ-77242113	Crinetics Pharmaceuticals, Inc. (CRNX)
ly4100511	ELI LILLY & Co (LLY)
orka-001	Oruka Therapeutics, Inc. (ORKA)
orka-001 induction dose	Oruka Therapeutics, Inc. (ORKA)
orka-001 maintenance dose	Oruka Therapeutics, Inc. (ORKA)
orka-002	Oruka Therapeutics, Inc. (ORKA)
orka-003	Oruka Therapeutics, Inc. (ORKA)
orka-021	Oruka Therapeutics, Inc. (ORKA)
tak-279	TAKEDA PHARMACEUTICAL CO LTD (TKPHF)
tqh3906	SPRING PHARMACEUTICAL GROUP, INC. (CYIG)

Phase 1(1)

Drug	Company
PN-881	Protagonist Therapeutics, Inc (PTGX)

Preclinical(1)

Drug	Company
krillase	MARIZYME, INC. (MRZM)

Unknown(1)

Drug	Company
amputee garment for use with lympha press optimal plus	AC Immune SA (ACIU)

BLA Filed(1)

Drug	Company
Icotyde	Protagonist Therapeutics, Inc (PTGX)

Phase 1/Phase 2(6)

Phase 4(8)

Drug	Company
atorvastatin	NOVARTIS AG (NVSEF)
atorvastatin	Novartis AG (NVS)
Deucravacitinib	BRISTOL MYERS SQUIBB CO (BMY)
Deucravacitinib	AbbVie Inc. (ABBV)
Tapinarof	Organon & Co. (OGN)
tapinarof cream, 1%	Organon & Co. (OGN)
Triamcinolone	Clearside Biomedical, Inc. (CLSDQ)
ustekinumab	GH Research PLC (GHRS)

BioSniper tracks 67 drugs in development for Plaque across 31 companies.

There are 1 clinical trial targeting Plaque tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.